Submission declined on 10 June 2024 by
Liance (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. This submission does not appear to be written in
the formal tone expected of an encyclopedia article. Entries should be written from a
neutral point of view, and should refer to a range of
independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid
peacock terms that promote the subject.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
| ![]() |
Submission declined on 16 May 2024 by
HitroMilanese (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
HitroMilanese 54 days ago. | ![]() |
Submission declined on 16 May 2024 by
Umakant Bhalerao (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
Umakant Bhalerao 55 days ago. | ![]() |
Mark Connors | |
---|---|
Alma mater | Temple University (BA, MD) |
Known for | Research on Long-term nonprogressors |
Scientific career | |
Fields | Immunology |
Mark Connors is a researcher at the National Institutes of Health (NIH) specializing in HIV/AIDS. He serves as the Chief of the HIV-Specific Immunity Section at the National Institute of Allergy and Infectious Diseases (NIAID), where he oversees efforts to understand and enhance the immune response to HIV and other viruses. His research focuses on identifying effective immune responses to viruses, which are crucial for developing vaccines and immunotherapies. [1]
Dr. Connors received his medical degree from Temple University, followed by pediatric training at Tufts Medical Center, and infectious diseases training at NIAID and the Children's Hospital of Philadelphia. He has been with the NIH since 1989, initially studying the immune response to respiratory viruses before shifting his focus to HIV in 1994. His career highlights include pioneering studies on the immunologic control of HIV, particularly in Long-term nonprogressor or "elite controllers" who can control HIV without antiretroviral therapy. The study of this group of patients has provided insights for our understanding of an effective immune response to HIV and provided insights into potential strategies for HIV treatment and prevention. [1]
In addition to his work on the cellular immune response to HIV, he has made numerous contributions to our understanding of the antibody response. These include identifying patients with broad antibody responses to HIV, and from these patients isolating broad and potent monoclonal antibodies that define sites of vulnerability on HIV envelope protein. These antibodies include isolation of broad and potent antibodies 10E8, 35O22, and N6, among others a potent antibody which can neutralize nearly all HIV strains. [2] [3] [4]This discovery has broad implications for the development of HIV treatments and vaccines, as it targets a crucial part of the virus that attaches to immune cells, making it a promising candidate for therapeutic use.
Dr. Connors' work has not only contributed to our understanding of HIV but also has implications for broader immunological research and public health. His publications and contributions to the scientific community are recognized and continue to influence the field of HIV research.
Submission declined on 10 June 2024 by
Liance (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. This submission does not appear to be written in
the formal tone expected of an encyclopedia article. Entries should be written from a
neutral point of view, and should refer to a range of
independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid
peacock terms that promote the subject.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
| ![]() |
Submission declined on 16 May 2024 by
HitroMilanese (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
HitroMilanese 54 days ago. | ![]() |
Submission declined on 16 May 2024 by
Umakant Bhalerao (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
Umakant Bhalerao 55 days ago. | ![]() |
Mark Connors | |
---|---|
Alma mater | Temple University (BA, MD) |
Known for | Research on Long-term nonprogressors |
Scientific career | |
Fields | Immunology |
Mark Connors is a researcher at the National Institutes of Health (NIH) specializing in HIV/AIDS. He serves as the Chief of the HIV-Specific Immunity Section at the National Institute of Allergy and Infectious Diseases (NIAID), where he oversees efforts to understand and enhance the immune response to HIV and other viruses. His research focuses on identifying effective immune responses to viruses, which are crucial for developing vaccines and immunotherapies. [1]
Dr. Connors received his medical degree from Temple University, followed by pediatric training at Tufts Medical Center, and infectious diseases training at NIAID and the Children's Hospital of Philadelphia. He has been with the NIH since 1989, initially studying the immune response to respiratory viruses before shifting his focus to HIV in 1994. His career highlights include pioneering studies on the immunologic control of HIV, particularly in Long-term nonprogressor or "elite controllers" who can control HIV without antiretroviral therapy. The study of this group of patients has provided insights for our understanding of an effective immune response to HIV and provided insights into potential strategies for HIV treatment and prevention. [1]
In addition to his work on the cellular immune response to HIV, he has made numerous contributions to our understanding of the antibody response. These include identifying patients with broad antibody responses to HIV, and from these patients isolating broad and potent monoclonal antibodies that define sites of vulnerability on HIV envelope protein. These antibodies include isolation of broad and potent antibodies 10E8, 35O22, and N6, among others a potent antibody which can neutralize nearly all HIV strains. [2] [3] [4]This discovery has broad implications for the development of HIV treatments and vaccines, as it targets a crucial part of the virus that attaches to immune cells, making it a promising candidate for therapeutic use.
Dr. Connors' work has not only contributed to our understanding of HIV but also has implications for broader immunological research and public health. His publications and contributions to the scientific community are recognized and continue to influence the field of HIV research.